GfK Researchers Featured
in MM&M's Pipeline 2009

What are the promising drugs of 2009? Medical Marketing & Media’s “Pipeline” looks at pharmaceutical products under development and highlights 10 that are generating the most buzz in major categories such as cardiovascular, diabetes, central nervous system, oncology and respiratory. Five GfK U.S. Healthcare Companies marketing researchers are featured in the piece providing their expert opinions on both the therapeutic classes and specific drugs covered.

To download Medical Marketing & Media’s “Pipeline 2009,” click here.





For more insights on these therapeutic areas from the experts included in the article, please contact the appropriate GfK U.S. Healthcare Companies consultant listed below:

Michael Galvin, Ph.D
Senior Vice President & Oncology Expert
GfK V2
mgalvin@gfkv2.com

Kim Lazarus, M.B.A.
Vice President & Category Business Leader, Neurology
GfK Market Measures
klazarus@gfkmm.com

Anna Marie Napolitano
Vice President & Category Business Leader, Cardiovascular
GfK Market Measures
anapolitano@gfkmm.com

Geoff Penney
Vice President & Category Business Leader, Psychiatry
GfK Market Measures
gpenney@gfkmm.com

Sue Ramspacher, M.A.
Senior Vice President & Category Business Leader, Respiratory
GfK Market Measures
sramspacher@gfkmm.com